Skip to Main content Skip to Navigation
Master Thesis

Conception et test d'un modèle de suivi pharmaceutique des patients traités par anticancéreux et hormonothérapie par voie orale

Abstract : Context : The more and more frequent appeal in oral anticancerous treatments responsible for numerous adverse effects led to us to study the management of this therapeutics by the ambulant patients. Objective: measure in a qualitative way the interest of a regular pharmaceutical consultation in the ambulant monitoring of the cancerous patients treated by chemotherapy and hormonal therapy by oral way. Method : Two pharmaceutical guides of maintenance standardized were formalized from the data of literature. These frames of reference allowed to question to a semi directive mode a cohort of cancerous patients treated by oral way. The first maintenance took place during a meeting with the patient, then the monitoring was telephone. Main results : The implement was tested on 28 patients over a period of 6,5 months, with an average of 3 discussions accomplished by patient. 22 patients had recourse to self-medication; 18 in complementary therapies; and 10 introduced an incomplete adherence. Pharmaceutical interventions concerned prevention and taking care of the adverse effects of the anticancerous to 28 patients. Discussion-conclusion : Oral antineoplastic agents constitute a source of risks for the patient, in terms of drug interactions, of adverse effects, maladjusted mode of catch and non-adherence. It is necessary to reassure the catch of this type of drugs via an implement of specific patient education. Supplementary studies must be led, to insert into a multidisciplinary step presentations and behaviours of the patients faced with treatments.
Document type :
Master Thesis
Complete list of metadata

Cited literature [34 references]  Display  Hide  Download

https://dumas.ccsd.cnrs.fr/dumas-00592342
Contributor : Jean-Hugues Morneau <>
Submitted on : Thursday, May 12, 2011 - 10:14:09 AM
Last modification on : Tuesday, May 11, 2021 - 11:36:17 AM
Long-term archiving on: : Saturday, August 13, 2011 - 2:37:49 AM

Identifiers

  • HAL Id : dumas-00592342, version 1

Citation

Aurélie Rignon. Conception et test d'un modèle de suivi pharmaceutique des patients traités par anticancéreux et hormonothérapie par voie orale. Sciences pharmaceutiques. 2009. ⟨dumas-00592342⟩

Share

Metrics

Record views

356

Files downloads

2580